Solange Silveira Pereira

Solange Silveira Pereira

Auto-generated profile, based on publicly available information

Solange Silveira Pereira

Departamento de Nutrição e Saúde, Universidade Federal de Viçosa, Viçosa 36570-900, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2014 in Current Obesity Reports
Verified
Journal Article
Closed access
PDF file
SPSolange S. Pereira
Solange S. Pereira
Jacqueline Isaura Alvarez-LeiteJacqueline Isaura Alvarez-Leite
Jacqueline Isaura Alvarez-Leite

1 June 2013 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
FSFabíola Lacerda Pires Soares
Fabíola Lacerda Pires Soares
RMRafael de Oliveira Matoso
Rafael de Oliveira Matoso
LTLílian Gonçalves Teixeira
Lílian Gonçalves Teixeira
ZMZélia Menezes
Zélia Menezes
SPSolange Silveira Pereira
Solange Silveira Pereira
Jacqueline Isaura Alvarez-LeiteJacqueline Isaura Alvarez-Leite
Jacqueline Isaura Alvarez-Leite

1 July 2014 in Nutrition
Verified
Journal Article
Closed access
SPSolange Pereira
Solange Pereira
LTLílian Teixeira
Lílian Teixeira
EAEdenil Aguilar
Edenil Aguilar
MOMarina Chaves de Oliveira
Marina Chaves de Oliveira
ASAlexandre Savassi-Rocha
Alexandre Savassi-Rocha
Jacqueline Isaura Alvarez-LeiteJacqueline Isaura Alvarez-Leite
Jacqueline Isaura Alvarez-Leite

1 November 2015 in Nutrition
Verified
Journal Article
Closed access
GRGisele K. Rodrigues
Gisele K. Rodrigues
CRCristina M.M. Resende
Cristina M.M. Resende
DDDanielle F. Durso
Danielle F. Durso
LRLorena A.A. Rodrigues
Lorena A.A. Rodrigues
JSJosé Luiz P. Silva
José Luiz P. Silva
Jacqueline Isaura Alvarez-LeiteJacqueline Isaura Alvarez-Leite
Jacqueline Isaura Alvarez-Leite

1 July 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
NPNathalia T. Pietrani
Nathalia T. Pietrani
CFCláudia N. Ferreira
Cláudia N. Ferreira
KRKathryna F. Rodrigues
Kathryna F. Rodrigues
LPLuiza O. Perucci
Luiza O. Perucci
FCFernanda S. Carneiro
Fernanda S. Carneiro
KBKarina Braga Borges
Karina Braga Borges

1 May 2014 in Journal of Receptor, Ligand and Channel Research
Verified
Journal Article
Open access
SPSolange Pereira
Solange Pereira
JAJacqueline Alvarez-Leite
Jacqueline Alvarez-Leite
Adipose tissue is an extremely active organ, and plays a fundamental role in the genesis of comorbidities associated with obesity. Since the discovery of leptin, an important focus has been assigned to adipose tissue as a key organ in the pathogenesis of metabolic disorders. The influence on the genesis of comorbidities associated with obesity is directly related to the pattern of adipokine secretion, the bioactive molecules produced on adipose tissue. The imbalance of adipokines consequent to the expansion of adipose tissue has been implicated in the development of the low-grade chronic inflammation seen in obesity. Adipokines act in a paracrine, autocrine, and endocrine fashion, influencing cytokine and chemokine secretions and hormonal and growth factors, as well as interfering with actions of insulin and lipid and glucose metabolism. The main adipokines include leptin, adiponectin, resistin, tumor-necrosis factor, interleukin 6, chemokine (C–C motif) ligand 2, interleukin 10, and transforming growth factor-β. The imbalance between pro- and anti-inflammatory adipokines on adipose tissue results in insulin resistance and the development of metabolic syndrome, type 2 diabetes, and cardiovascular disease. However, not all obese individuals develop these comorbidities or metabolic changes. Metabolically normal obese or metabolically healthy obese individuals have been the focus of research because of their absence of comorbidities. The profile of adipokines in adipose tissue of these individuals can be protective for the development of insulin resistance and metabolic disorders. This review emphasizes the roles of adipokines, the signaling pathways involved in the pathogenesis of inflammation and insulin resistance, and the profile found in metabolically healthy obese individuals.